A Study to Examine APL-130277 in Patients With Parkinson's Disease
Clinical trial NCT02228590 · COMPLETED
Trial details
- NCT number
- NCT02228590
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-31
- Primary completion
- 2014-11-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.